Hospitalization and Survival in Patients Using Epoprostenol for Injection in the PROSPECT Observational Study

BACKGROUND: Few studies have prospectively reported outcomes in patients with pulmonary arterial hypertension (PAH) treated with epoprostenol in the modern-day era of oral therapy and combination treatments. The Registry to Prospectively Describe Use of Epoprostenol for Injection (Veletri, prolonged...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Chest
Main Authors: Frantz, Robert P., Schilz, Robert J., Chakinala, Murali M., Badesch, David B., Frost, Adaani E., McLaughlin, Vallerie V., Barst, Robyn J., Rosenberg, Daniel M., Miller, Dave P., Hartline, Brian K., Benton, Wade W., Farber, Harrison W.
Formato: Artigo
Idioma:Inglês
Publicado em: American College of Chest Physicians 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4314821/
https://ncbi.nlm.nih.gov/pubmed/25320967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-1004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados